Live Breaking News & Updates on Respir med

Stay informed with the latest breaking news from Respir med on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Respir med and stay connected to the pulse of your community

Seasonal influenza and its prevention

Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world1. It is a serious condition

United-kingdom , Scotland , Sanofi-pasteur , Centers-for-disease , Allard , International-longevity-centre , Public-health-matters , European-respiratory-journal , Severe-complications , Heart-disease , Pandemic-influenza , Longevity-centre

Systemic sclerosis

Systemic sclerosis, also known as scleroderma, is a rare and complex autoimmune connective-tissue
disease. Once considered an untreatable and unpredictable condition, research advancements
have improved our understanding of its disease pathogenesis and clinical phenotypes
and expanded our treatment armamentarium. Early and accurate diagnosis is essential,
while ongoing efforts to risk stratify patients have a central role in predicting
both organ involvement and disease progression. A holistic approach is required when
choosing the optimal therapeutic strategy, balancing the side-effect profile with
efficacy and tailoring the treatment according to the goals of care of the patient.

Elhai , Ma-an , Jordan , United-states , United-kingdom , Colombo , Western , Sri-lanka , Lescoat , Bretagne , France , Brazil

World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen and CanSinoBIO, First Public Booster Immunization in China.

Late in 2021, Aerogen (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's Recombinant

China , Shanghai , United-states , Xuefeng , Hunan , Tianjin , Ireland , Chinese , America , Mac-giolla-eain , Leo-clancy , John-power

New analyses in real-world setting support the effectiveness of Fasenra in severe eosinophilic asthma

New findings from the XALOC programme support the real-world effectiveness of Fasenra (benralizumab) in the management of patients with severe eosinophilic asthma (SEA), showing reductions in annualised asthma exacerbation rate (AAER), improvements in asthma control and the ability to achieve clinical remission ...

Japan , Germany , United-kingdom , Belgium , Italy , Cambridge , Cambridgeshire , Canada , Switzerland , Spain , David-jackson , Company-on-twitter

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Esther-jr , Pediatr-pulmonol , J-clin-pharmacol , Institute-for-clinical , Transl-med , Englj-med , Cyst-fibros , Pharmacol-ther , Database-syst-rev

Correction to Lancet Respir Med 2022; 10: e36–37

Correction to Lancet Respir Med 2022; 10: e36–37
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Respir-med ,

Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder

Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

China , Laos , Canada , South-korea , France , London , City-of , United-kingdom , Han , French , Lao , Canadian

GETting to know the many causes and faces of COPD

GETting to know the many causes and faces of COPD
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Canada , Canadian , Allocation-of-national-institutes-health , Respir-med , Early-detection , Lung-cancer , National-institutes , Lancet-respiratory ,

Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan

Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South-africa , South-korea , London , City-of , United-kingdom , Han , South-african , Nat-genet , Haydn-walters , Clin-epigenetics , Ann-neurosci , Soler-artigas

Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis – Authors' reply

Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis – Authors' reply
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Netherlands , Dutch , Brian-lipworth , Airway-diseases , Advisory-board-of-the-dutch-patient-society , European-rhinologic-society , European-forum-for-research , Netherlands-organisation-for-health-research , Elsevier-ltd , Novartis , Respir-med , Position-paper